DIAMAZE "cut and paste"Hopefully Diamaze development will be updated later this year.
Since Nov 2021 (with q4 and full year release) we have been getting the exact same update.
And while the update is100% accurate, a more detailed timeline guesstimate (esp re Trials) would be very much appreciated,
Currently (as per the last 4 quarterly reports)
We are continuing with our development of DiaMaze® (diamine oxidase). DiaMaze® is an enzyme targeted to persons suffering from histamine intolerance and will be marketed as a nutraceutical. While we continue to make good progress, development of this product relies on a number of third-party suppliers whose deliverables have been slower than expected owing to COVID-19 constraints.